The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 2 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 3 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 4 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 5 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 6 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 7 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 8 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 9 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 10 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 11 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 12 of 13

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid — Image 13 of 13

3D model · NIH 3D

The N-terminal domain of PA endonuclease from the influenza H1N1 virus in complex with 6-(3-(1H-tetrazol-5-yl)phenyl)-3-hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid

Platform: NIH 3D
Price: Free
License: CC-BY; Print, modify and use commercially — credit the author.
Formats: WRLGLBSTLX3D

8 Downloads
202 Views

Author:Meghan McCarthy

Published 2019-07-19

Description

PDB Classifiation: HYDROLASE/HYDROLASE INHIBITOR

Tags

influenza inhibitor hydrolase-hydrolase inhibitor complex h1n1 pa endonuclease phaser escherichia coli bl21 refmac 5.8.0230 apex

More like this

Similar models

2.26 A resolution structure of MERS 3CL protease in complex with inhibitor 7i

2.26 A resolution structure of MERS 3CL protease in complex with inhibitor 7i

NIH 3D publicacionesenlinkedIn1

Staphylococcus aureus FtsZ 12-316 G196S complexed with TXA6101

Staphylococcus aureus FtsZ 12-316 G196S complexed with TXA6101

Staphylococcus aureus FtsZ 12-316 complexed with TXA6101

Staphylococcus aureus FtsZ 12-316 complexed with TXA6101

Crystal structure of influenza A virus neuraminidase N5 complexed with Zanamivir

Crystal structure of influenza A virus neuraminidase N5 complexed with Zanamivir

NIH 3D laurelleber

X-ray crystal structure of Pf-M17 in complex with inhibitor (6k) and regulatory zinc ion

X-ray crystal structure of Pf-M17 in complex with inhibitor (6k) and regulatory zinc ion

Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR250

Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR250

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1741969146

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1741969146

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z44592329

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z44592329

Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR251

Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR251

PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1849009686 (Mpro-x1086)

PanDDA analysis group deposition SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1849009686 (Mpro-x1086)

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z30932204

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z30932204

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1587220559

PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 main protease in complex with Z1587220559

Names are used only to indicate the source of a result. Polyzon is not affiliated with the listed sites.